Back to top

Tale of the Tape

Zacks Equity Research

Investors are Betting Against Bio-Reference Laboratories Inc (BRLI), Should You?
August 28, 2013

Trades from $3

Many investors appear to be quite bearish on Bio-Reference Laboratories Inc , especially if you look at the percentage of the float that is sold short for this stock. Currently, 37.58% of the float is sold short, suggesting an extreme level of bearishness for BRLI.

However, it is worth noting that earnings estimates have actually been moving higher for the company, despite the pessimism. Thanks to these rising estimates, we actually have a Zacks Rank #2(Buy) on BRLI, so we clearly don’t believe in the negativity surrounding this firm, and are instead looking for shares of BRLI to move higher in the weeks ahead.